Danone Recalls Aptamil Baby Formula in Germany, Document Reveals

• The recall affects Aptamil batches produced during a four-month window from May to August 2025
• Danone Deutschland told wholesaler Alliance Healthcare that remaining stock should be minimal due to subsequent deliveries of new products
• The action is linked to a wider toxin contamination issue that originated with Nestle baby formula products

Danone Recalls Aptamil Baby Formula in Germany Amid Toxin Contamination Concerns

French food group Danone has recalled at least three batches of its Aptamil baby formula in Germany due to potential toxin contamination, according to a letter to wholesaler Alliance Healthcare dated January 26. The recall affects products manufactured between May and August 2025.

Key Details:

• The recall is part of a broader contamination scare that initially involved Nestle products
• Danone Deutschland instructed Alliance Healthcare to withdraw the affected batches immediately
• The company believes minimal stock remains at the wholesaler level, as subsequent deliveries of new products have since been received
• The letter was published by online pharmacy Shop Apotheke

Market Implications:

This recall represents a significant reputational and operational challenge for Danone, particularly in its infant nutrition segment, which is a key revenue driver for the company. The contamination issue extending beyond Nestle to Danone suggests a potentially wider industry problem that could erode consumer confidence in baby formula products across major European brands.

The incident occurs at a sensitive time for the infant formula market, where safety and quality are paramount to brand loyalty. Any prolonged contamination concerns could impact sales, trigger regulatory scrutiny, and potentially lead to market share losses as parents seek alternative brands.

Companies Affected:

• Danone (primary)
• Nestle (initial contamination scare)
• Alliance Healthcare (wholesaler)
• Shop Apotheke (online pharmacy reporting the issue)

The scope and source of the toxin contamination remain unclear, warranting close monitoring of further developments from both companies and German health authorities.